Literature DB >> 19013407

Posttraumatic avascular necrosis of the talus.

Stephane Léduc1, Michael P Clare, G Yves Laflamme, Arthur K Walling.   

Abstract

Avascular necrosis of the talus is one the most challenging problems encountered in posttraumatic reconstruction of the hindfoot. Since the first description of the talus injury in 1608 by Fabricius of Hilden, our knowledge of the talar anatomy, injuries, sequelae, and management has increased significantly. Adequate knowledge of the etiology, the extent of the disease, and the degree of patient symptoms are required to determine optimal treatment.

Entities:  

Mesh:

Year:  2008        PMID: 19013407     DOI: 10.1016/j.fcl.2008.09.004

Source DB:  PubMed          Journal:  Foot Ankle Clin        ISSN: 1083-7515            Impact factor:   1.653


  5 in total

1.  All Arthroscopic Remnant-Preserving Technique to Reconstruct the Lateral Ankle Ligament Complex.

Authors:  Jianchao Gui; Yiqiu Jiang; Yang Li; Tianqi Tao; Wang Li; Kaibing Zhang; Wangxiang Yao; Peilong Dong
Journal:  Arthrosc Tech       Date:  2017-05-08

2.  [Ankle joint prosthesis for bone defects].

Authors:  C Lampert
Journal:  Orthopade       Date:  2011-11       Impact factor: 1.087

3.  Anatomical basis of a pedicled cuboid bone graft based on the lateral tarsal artery for talar avascular necrosis.

Authors:  Lu Bai; Yan-Bin Peng; San-Biao Liu; Xiao-Xiao Xie; Xue-Min Zhang
Journal:  Surg Radiol Anat       Date:  2021-07-07       Impact factor: 1.246

4.  Successful Treatment of Early Talar Osteonecrosis by Core Decompression Combined with Intraosseous Stem Cell Injection: A Case Report.

Authors:  Mika T Nevalainen; Jussi P Repo; Maija Pesola; Jukka P Nyrhinen
Journal:  J Orthop Case Rep       Date:  2018 Jan-Feb

5.  Conservative tibiotalocalcaneal fusion for partial talar avascular necrosis in conjunction with ankle and subtalar joint osteoarthritis in Kashin-Beck disease: A case report.

Authors:  Liubing Li; Ying Wang; Zhenhua Zhu; Jupu Zhou; Shuyuan Li; Jianzhong Qin
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.